Abbott India Limited vs Solar Industries India Limited
Put two companies head-to-head — source-verified financials and AI-analysed SWOT, together in one view.
Abbott India Limited (Pharmaceuticals) and Solar Industries India Limited (Industrial explosives and defence manufacturing) go head-to-head here — with source-verified financials and a full SWOT breakdown side by side on Nexvora Intelligence. On the figures reported, Abbott India Limited leads on Net profit (approx.); Solar Industries India Limited leads on Revenue (approx.).
Abbott India Limited leads on Net profit (approx.); Solar Industries India Limited leads on Revenue (approx.).
Choose Abbott India if you want exposure to branded pharmaceuticals with strong parentage, recognized chronic and specialty brands, and an established doctor and pharmacy network. Choose Solar Industries if you prefer exposure to industrial explosives and defence, with diversification across mining, infrastructure, exports, and defence plus backward integration in energetic materials. The right choice depends on whether the buyer prioritizes a higher-margin domestic pharma portfolio with price-control risk or a more cyclical, regulation-heavy industrial and defence business tied partly to government procurement timelines.
Grounded in the verified figures and SWOT shown — guidance, not investment advice.
Head-to-head highlights
| Metric | Abbott India Limited | Solar Industries India Limited | Basis |
|---|---|---|---|
| Revenue (approx.) | INR 5,800-6,200 crore | Approximately INR 6,000–7,000 crore | AI estimate |
| Net profit (approx.) | INR 1,100-1,300 crore | Approximately INR 800–1,000 crore | AI estimate |
An arrow marks the larger reported figure — a factual comparison, not a quality judgement. Verified figures come from official filings; AI estimates are approximate and unverified.
Abbott India Limited
Pharmaceuticals · India
Abbott India Limited is an Indian pharmaceutical company and a listed subsidiary of Abbott Laboratories. It markets branded prescription and over-the-counter healthcare products across therapeutic areas such as gastroenterology, women's health, metabolic disorders, central nervous system, pain management, and vaccines.
Verified financials
No source-verified financials available.
Strengths
- Strong parentage from Abbott Laboratories
- Recognized brands in chronic and specialty therapeutic areas
- Established doctor and pharmacy distribution network
- Focus on higher-margin branded formulations
Weaknesses
- High dependence on the Indian domestic pharmaceutical market
- Limited scale compared with India's largest pharma companies
- Exposure to price controls on essential medicines
- Relatively concentrated portfolio in select therapies
Opportunities
- Growth in chronic disease treatment demand in India
- Expansion in women's health, gastroenterology, and metabolic care
- Digital engagement with physicians and patients
- Leveraging Abbott's global portfolio for India-specific launches
Threats
- Intense competition from Indian generic and branded-generic companies
- Regulatory pricing pressure from India's drug price control regime
- Changes in physician prescribing behavior
- Supply chain and input cost volatility
Solar Industries India Limited
Industrial explosives and defence manufacturing · India
Solar Industries India Limited manufactures industrial explosives, initiating systems, and related products used in mining, infrastructure, and construction. The company has also built a growing defence business focused on ammunition, propellants, warheads, and related energetic materials.
Verified financials
No source-verified financials available.
Strengths
- Strong position in India’s industrial explosives market
- Diversified exposure to mining, infrastructure, exports, and defence
- Backward integration in energetic materials
- Established manufacturing and distribution network
Weaknesses
- Operations involve high regulatory and safety compliance requirements
- Exposure to cyclical demand from mining and infrastructure sectors
- Defence revenue can be dependent on government procurement timelines
Opportunities
- Growth in Indian mining and infrastructure activity
- Rising defence indigenization and local procurement
- Expansion in export markets
- Higher-value defence and space-related energetic products
Threats
- Raw material price volatility
- Accidents or safety incidents affecting operations
- Delays in defence orders or approvals
- Competition from multinational explosives companies
Frequently asked
Answered from source-verified figures on this page.
Abbott India Limited vs Solar Industries India Limited: which company leads overall?
Abbott India Limited leads on Net profit (approx.); Solar Industries India Limited leads on Revenue (approx.).
Related market reports
Deep-dive intelligence on the markets these companies compete in.
India Defense Equipment Market — Intelligence Report
Global Industrial Automation & Robotics Market — Intelligence Report
Global Autonomous Mobile Robots for Warehousing and Fulfillment Market — Intelligence Report
Global Humanoid Robotics for Industrial Labor and Field Services Market — Intelligence Report
AI Analyst
Insights and answers generated live from Abbott India Limited vs Solar Industries India Limited's verified data. Modeled estimates — not investment advice.
- Abbott India Limited is an Indian pharmaceutical company and a listed subsidiary of Abbott Laboratories.
- Abbott India markets branded prescription and over-the-counter healthcare products across gastroenterology, women's health, metabolic disorders, central nervous system, pain management, and vaccines.
- Solar Industries India Limited manufactures industrial explosives, initiating systems, and related products for mining, infrastructure, and construction.
- Notable point: Solar Industries India has expanded beyond industrial explosives into defence manufacturing focused on ammunition, propellants, warheads, and related energetic materials.